Compare WOR & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WOR | PTCT |
|---|---|---|
| Founded | 1955 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 5.3B |
| IPO Year | N/A | 2013 |
| Metric | WOR | PTCT |
|---|---|---|
| Price | $58.06 | $75.56 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 17 |
| Target Price | $61.00 | ★ $73.76 |
| AVG Volume (30 Days) | 141.9K | ★ 2.2M |
| Earning Date | 12-16-2025 | 11-04-2025 |
| Dividend Yield | ★ 1.30% | N/A |
| EPS Growth | ★ 179.34 | N/A |
| EPS | 2.14 | ★ 8.94 |
| Revenue | $1,200,161,000.00 | ★ $1,779,150,000.00 |
| Revenue This Year | $14.93 | $128.32 |
| Revenue Next Year | $4.45 | N/A |
| P/E Ratio | $27.27 | ★ $8.46 |
| Revenue Growth | 0.76 | ★ 97.54 |
| 52 Week Low | $37.88 | $35.95 |
| 52 Week High | $70.91 | $87.50 |
| Indicator | WOR | PTCT |
|---|---|---|
| Relative Strength Index (RSI) | 65.98 | 50.79 |
| Support Level | $54.59 | $73.09 |
| Resistance Level | $55.79 | $78.77 |
| Average True Range (ATR) | 1.04 | 3.15 |
| MACD | 0.49 | -1.02 |
| Stochastic Oscillator | 98.12 | 18.45 |
Worthington Enterprises Inc is a designer and manufacturer of products and services, including manufactured metal products. The company operates under two reportable operating segments: Consumer Products and Building Products. The consumer Products business has a diverse product offering in the tools, outdoor living and celebrations categories, including propane-filled cylinders for torches, handheld torches, specialized hand tools, drywall tools, accessories and gas grills, and others. And the Building Products business engaged in providing pressurized containment solutions, providing critical components in the residential, non-residential, and repair and remodel end markets through essential categories. The company derives majority of the revenue from Building Products segment.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.